EUVIMEDDescoperă EUVIMED
Übersichtsarbeit

Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel

Joshua Burshtein, Milaan Shah, Danny Zakria, April W Armstrong, Alexandra K Golant, Alice B Gottlieb, Jeffrey M Weinberg, Leon Kircik, George Han, Richard G Langley, Andrea L Neimann, Mark Lebwohl

Journal of Drugs in Dermatology · 2024

DOI: 10.36849/jdd.8246 ↗

At a glance

Übersichtsarbeit in Journal of Drugs in Dermatology, 2024. Written by Joshua Burshtein and 11 co-authors. Major MEDLINE topics: Psoriasis, Consensus, Antibodies, Monoclonal, Humanized, Interleukin-17. Cited 2 times so far (Crossref).

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Niciun rezumat disponibil.

Subjects

MeSH terms (MEDLINE)

PsoriasisConsensusAntibodies, Monoclonal, HumanizedInterleukin-17HumansDermatologic AgentsDelphi TechniqueSeverity of Illness Index

Substances

bimekizumabAntibodies, Monoclonal, HumanizedInterleukin-17Dermatologic AgentsIL17A protein, human

Cite

APA

Burshtein, J., Shah, M., Zakria, D., Armstrong, A. W., Golant, A. K., Gottlieb, A. B., Weinberg, J. M., Kircik, L., Han, G., Langley, R. G., Neimann, A. L., & Lebwohl, M. (2024). Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.8246

Vancouver

Burshtein J, Shah M, Zakria D, Armstrong AW, Golant AK, Gottlieb AB, et al. Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel. Journal of Drugs in Dermatology. 2024. doi:10.36849/jdd.8246

BibTeX
@article{Burshtein2024,
  author = {Burshtein, Joshua and Shah, Milaan and Zakria, Danny and Armstrong, April W and Golant, Alexandra K and Gottlieb, Alice B and Weinberg, Jeffrey M and Kircik, Leon and Han, George and Langley, Richard G and Neimann, Andrea L and Lebwohl, Mark},
  title = {Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel},
  journal = {Journal of Drugs in Dermatology},
  year = {2024},
  doi = {10.36849/jdd.8246}
}
Start for free →